Abeta1-42 detection reagent based on fluorescence immunochromatography
The detection of Aβ1- was solved by using fluorescein isothiocyanate-silica putaway double-structure fluorescent microspheres and specific preservation solution in the detection reagent card for detecting Aβ1-42 in fluorescent immunochromatography. 42 The problems of large fluctuations in the reagent card results and low efficiency have achieved more reliable and efficient detection results.
Patent Information
- Application Number
- CN202411327667.2
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-09-23
- Publication Date
- 2024-12-03
- Estimated Expiration
- 2044-09-23
AI Technical Summary
The existing fluorescence immunochromatography method detects that the Aβ1-42 reagent card has problems such as large fluctuations in the measurement results and low measurement efficiency, which leads to unreliable and low efficiency of the detection results.
Detection reagent cards for Aβ1-42 were prepared by using a specific preservation solution, including the preparation of fluorescein isothiocyanate-silica putaway double structure fluorescent microspheres on a fluorescent label binding pad and Antibodies and antibodies are sprayed on the nitrocellulose membrane, combined with blocking treatment and desalting purification, improving the stability and binding efficiency of fluorescent microspheres.
The fluctuations in the measurement results are significantly reduced, the detection efficiency is improved, and the detection results are more reliable and completed in a short time, providing a wide time window to read accurate results.
Smart Images

Figure FT_1 
Figure FT_2 
Figure FT_3
Abstract
Description
Technical Field
[0001] The present invention relates to the field of immunoassay technology, and to an Aβ1-42 detection reagent based on fluorescent immunochromatography. Specifically, it relates to a detection reagent card for detecting Aβ1-42 by fluorescent immunochromatography. Further, the present invention also relates to a reagent strip for preparing the detection reagent card. In particular, the reagent strip or reagent card of the present invention can solve the problem of fluctuations in the results of fluorescent immunochromatography assays, and the assay efficiency is significantly improved. Background Art
[0002] As we all know, Fluorescent Immunoassay (FIA) is a protein immunoassay technology based on antibody-antigen specific recognition, which detects and quantifies target molecules moving in chromatography paper through fluorescent signals. This technology is a combination of multiple disciplines such as immunology, fluorescence detection and biochemistry, and has the advantages of high sensitivity, high specificity, rapidity, simplicity, convenience, easy operation and low price. Fluorescent immunochromatography technology has been widely used in point-of-care testing (POCT) occasions.
[0003] The basic principle of fluorescence immunochromatography is typically Figure 1 Specifically, the fluorescent immunochromatography technique uses a strip-shaped fiber chromatography material (mostly nitrocellulose membrane) fixed with a detection line (i.e., T line, fixed with capture antibody Ab2, also called coated antibody) and a quality control line (i.e., C line, fixed with capture antibody Ab3, also called anti-antibody) as the stationary phase, and a test solution of the analyte as the mobile phase. The fluorescently labeled antibody Ab1 is fixed in the conjugate pad, and the analyte moves on the chromatography strip through capillary action.
[0004] For the analyte with macromolecular antigens (proteins, viruses, etc.) with multiple antigenic determinants, the "sandwich" double antibody sandwich immunochromatography method is usually used, that is, the test solution of the analyte first binds to the fluorescent labeled antibody under the action of the mobile phase, and then binds to the capture antibody Ab2 when it reaches the detection line (T line) to form a double antibody sandwich "sandwich" type. During the test, the sample solution will chromatograph upward under the capillary effect (depending on whether the analyte contains antigens) and two display results will appear: If the result is negative (no antigen in the sample to be tested), the sample does not bind to the fluorescently labeled antibody. The fluorescently labeled antibody is chromatographed with the test solution to the T line and does not bind to the coated antibody. It continues to move forward to the C line and is captured by the anti-antibody. The instrument can detect the fluorescence of the C line, but there is no fluorescence on the T line, so the result is negative. If it is positive (there is antigen in the sample to be tested), the sample antigen reacts and binds with the fluorescently labeled antibody to form a fluorescently labeled antigen-antibody complex. The complex is chromatographed with the test liquid to the T line, and combines with the coated antibody to form a "sandwich" double-antibody sandwich form of fluorescently labeled antibody Ab1-antigen-capture antibody Ab2 complex. Since the fluorescently labeled antibody fixed on the binding pad is excessive, the excess fluorescently labeled antibody continues to chromatograph with the test liquid to the C line, and combines with the capture antibody Ab3 to form a fluorescently labeled antibody Ab1-capture antibody Ab3 complex. The instrument can detect that both the T line and the C line are fluorescent, and the result is positive; In addition, in the case of a positive result, the antigen amount / concentration can be quantitatively calculated based on the fluorescence intensity ratio of the T line and the C line.
[0005] Those skilled in the art have designed fluorescent immunochromatography detection reagent strips or reagent cards or test kits for various occasions and objects using the above principle. Of course, according to the above principle, those skilled in the art can also easily design detection reagent strips or reagent cards or test kits of other immunochromatography patterns.
[0006] Generally speaking, the labeled antibody Ab1 is typically labeled with fluorescent microspheres. However, when designing a reagent card for detecting Aβ1-42, after fixing such fluorescent microsphere-labeled antibodies to the conjugate pad, it is regrettably found that the reagent cards for detecting Aβ1-42 designed using this principle have the problem of large fluctuations in measurement results, resulting in unreliable measurement results. In addition, these reagent cards may also have the problem of low measurement efficiency.
[0007] The basic composition and preparation method of some kits for detecting Aβ1-42 by fluorescence immunochromatography have been disclosed in the art. For example, CN115932241A (application number 202211735046.9) discloses a test reagent card for detecting Aβ1-42 and its preparation method and application, wherein the test reagent card includes a base plate and a sample pad, a fluorescent labeling binding pad, a nitrocellulose membrane and a water-absorbing pad; a test line and a quality control line are provided on the nitrocellulose membrane, the test line is coated with Aβ1-42 antibody, and the quality control line is coated with chicken IgY antibody; the fluorescent labeling binding pad is coated with fluorescently labeled anti-Aβ1-42 antibody and fluorescently labeled sheep anti-chicken IgY. The preparation method of the above-mentioned test reagent card includes pre-treating the fluorescent labeling binding pad and the nitrocellulose membrane, and assembling the sample pad, the pre-treated fluorescent labeling binding pad, the nitrocellulose membrane and the water-absorbing pad on the base plate, and finally obtaining a test reagent card, which can be used to prepare an Aβ1-42 test kit and detect Aβ1-42. It is believed that the advantage of this invention is that it can realize rapid detection of Aβ1-42, and the operation is simple, sensitive and accurate. For another example, CN116643055A (application number 202310653235.X) discloses a human beta amyloid protein Aβ1-42 detection kit, including a calibrator, a reagent A, a reagent B, a cleaning solution, an acridinium ester excitation solution and an acridinium ester pre-excitation solution, wherein the calibrator is a series of concentrations of Aβ1-42 antigens for establishing a standard curve, and the reagent A is an Aβ1-42 antibody solution containing a magnetic particle label, and the reagent B is an Aβ1-42 antibody solution containing an acridinium ester label. However, the Aβ1-42 detection reagent strips / cards or boxes disclosed in these documents still have some shortcomings, such as the failure to solve the problem that the fluorescent microspheres labeled with antibodies fluctuate greatly after being fixed to the conjugate pad, thereby causing the problem of unreliable measurement results, and / or the problem of low measurement efficiency.
[0008] Therefore, those skilled in the art expect to provide a detection reagent card capable of detecting Aβ1-42 by fluorescent immunochromatography made of fluorescent microspheres labeled with antibodies, which has the excellent characteristics of small fluctuation in the measurement results and high measurement efficiency. Summary of the invention
[0009] The object of the present invention is to provide a detection reagent card or a detection reagent strip for detecting Aβ1-42 using a fluorescent immunochromatography method, and / or another object of the present invention is to provide a storage solution for the detection reagent card or the detection reagent strip of Aβ1-42 using the fluorescent immunochromatography method. It has been unexpectedly found that by using the storage solution of the present invention to prepare a detection reagent card or a detection reagent strip for detecting Aβ1-42 using a fluorescent immunochromatography method, the detection reagent card or the detection reagent strip has the excellent characteristics of small fluctuations in the measurement results and high measurement efficiency when measuring Aβ1-42. The present invention is completed based on such a discovery.
[0010] To this end, the first aspect of the present invention provides a detection reagent strip for detecting Aβ1-42 by fluorescent immunochromatography, which, along the direction of chromatographic movement of the sample liquid, comprises: A bottom plate, and a sample pad, a fluorescent marker binding pad, a nitrocellulose membrane, and a water absorbent pad sequentially arranged on the bottom plate along the length direction of the bottom plate; One end of the sample pad in the chromatographic moving direction is overlapped above one end of the fluorescent label conjugate pad, the other end of the fluorescent label conjugate pad is overlapped above one end of the nitrocellulose membrane, and the other end of the nitrocellulose membrane is overlapped below the water absorbent pad; A detection line and a quality control line are sequentially arranged on the nitrocellulose membrane from the sample pad to the water absorption pad, wherein the detection line is coated with Aβ1-42 antibody, and the quality control line is coated with chicken IgY antibody; the fluorescent labeling binding pad is coated with fluorescently labeled anti-Aβ1-42 antibody and fluorescently labeled goat anti-chicken IgY; The test reagent strip is prepared by a method comprising the following steps: (1) Pretreatment of the sample pad: soaking the sample pad in a sample pad buffer solution, and drying the sample pad at room temperature after soaking to obtain a pretreated sample pad; (2) Pretreatment of fluorescent labeling conjugate pad: Take Na 2 SiO 3 Using tetraethyl orthosilicate as a blocking agent to react with fluorescein isothiocyanate, followed by treatment with p-ethyl-N,N-dimethylpropylcarbodiimide and nitrogen hydroxysuccinimide, a fluorescent microsphere suspension of fluorescein isothiocyanate-silica core-shell dual-structure fluorescent microspheres was prepared; The desalted and purified anti-Aβ1-42 antibody was added to the biotin solution to obtain biotin-anti-Aβ1-42 antibody; the fluorescent microsphere suspension was added to the desalted and purified biotin-anti-Aβ1-42 antibody, and stirred at room temperature for 1 hour to obtain fluorescent microsphere-biotin-anti-Aβ1-42 antibody; in addition, The desalted and purified goat anti-chicken IgY was added to the biotin solution to obtain biotin-goat anti-chicken IgY; the fluorescent microsphere suspension was added to the desalted and purified biotin-goat anti-chicken IgY, and stirred at room temperature for 1 hour to obtain fluorescent microsphere-biotin-goat anti-chicken IgY; Next, bovine serum albumin was added to the fluorescent microspheres-biotin-anti-Aβ1-42 antibody and fluorescent microspheres-biotin-goat anti-chicken IgY to a concentration of 1% for blocking treatment; 1 mL of preservation solution was added to the desalting column, and the blocked fluorescent microspheres-biotin-anti-Aβ1-42 antibody and blocked fluorescent microspheres-biotin-goat anti-chicken IgY were separated and purified using the desalting column; Mix the desalted and purified fluorescent microspheres-biotin-anti-Aβ1-42 antibody and the desalted and purified fluorescent microspheres-biotin-goat anti-chicken IgY in the preservation solution, spray the mixture onto the glass cellulose membrane at a volume of 4 μL / cm, and dry at 30° C. for 6 hours to obtain a fluorescent labeling conjugate pad; (3) Pretreatment of nitrocellulose membrane: Aβ1-42 antibody was diluted to 1 mg / mL with a first buffer, and chicken IgY antibody was diluted to 0.5 mg / mL with a second buffer, and the two were sprayed on the test line and quality control line of the nitrocellulose membrane at a rate of 6 cm / s at an amount of 2 μL / cm, respectively, and dried at 30° C. for 6 hours to obtain a nitrocellulose membrane containing a test line and a quality control line; (4) Assembly of the detection reagent strip: Assemble the pretreated sample pad, the pretreated fluorescent labeling binding pad, the pretreated nitrocellulose membrane, and the absorbent pad on the bottom plate, and then cut them into narrow strips with a width of 2 to 8 mm, which is the detection reagent strip for detecting Aβ1-42.
[0011] According to the detection reagent strip described in the first aspect of the present invention, in step (1), the sample pad is pretreated as follows: the sample pad is soaked in a sample pad buffer for 1 hour, and after the soaking is completed, it is dried at room temperature for 24 hours.
[0012] According to the detection reagent strip described in the first aspect of the present invention, in step (1), the sample pad buffer is composed of: 1% bovine serum albumin, 0.5% S9, and PBS buffer.
[0013] According to the detection reagent strip described in the first aspect of the present invention, in step (1), the PBS buffer refers to a phosphate buffer of pH 6.8, and its preparation method is: take 500ml of 0.2mol / L potassium dihydrogen phosphate solution, dilute it with water to about 900ml, add sodium hydroxide test solution to adjust the pH to 6.8, add water to dilute to about 950ml, then adjust the pH to 6.8 with sodium hydroxide test solution or phosphoric acid test solution, add water to 1000ml, shake well, and obtain.
[0014] According to the detection reagent strip of the first aspect of the present invention, in step (1), the sample pad has a width in the range of 10-30 mm and a length in the range of 100-400 mm, is arranged horizontally in the reagent strip, and after being cut, has a size of 10-30 mm in length and 3-10 mm in width.
[0015] According to the detection reagent strip of the first aspect of the present invention, in step (2), the operation of preparing fluorescein isothiocyanate-silica core-shell dual-structure fluorescent microspheres is as follows: 60 ml of anhydrous ethanol, 2 ml of ammonia water, 3 ml of tetraethyl orthosilicate, 1 ml of ultrapure water and 1 mg of fluorescein isothiocyanate are mixed evenly, reacted in a constant temperature water bath for 8 hours, and then 3% Na 2 SiO 3 The microspheres were sealed, and the size of the fluorescent microspheres was controlled by adjusting the pH value of the solution by adding hydrochloric acid. The active groups were modified on the surface of the fluorescent microspheres. The reaction solution was centrifuged at 1000×g for 15 min, the precipitate was collected, and suspended with 0.01M pH4.8 borate buffer, and the microsphere concentration was adjusted to OD450nm=0.2~0.25. Then, 100μL of 50mg / mL p-ethyl-N,N-dimethylpropylcarbodiimide and 150μL of 5mg / mL nitrogen hydroxysuccinimide were added, and the mixture was shaken and mixed. After incubation at room temperature for 25min, the mixture was centrifuged at 1000×g for 15min, and the precipitate was vacuum dried for precise stability. It was then suspended with 0.01M pH4.8 borate buffer, and the microsphere concentration was adjusted to OD450 of 0.45~0.5 to obtain a fluorescent microsphere suspension.
[0016] According to the detection reagent strip of the first aspect of the present invention, in step (2), the biotin solution is prepared using DMSO as a solvent to form a solution containing 10% biotin.
[0017] According to the detection reagent strip described in the first aspect of the present invention, in step (2), the addition ratio is: 0.06 mg biotin, 0.6 mg anti-Aβ1-42 antibody, 0.25 mg fluorescent microspheres, or the addition ratio is: 0.06 mg biotin, 0.6 mg goat anti-chicken IgY, 0.25 mg fluorescent microspheres.
[0018] According to the detection reagent strip described in the first aspect of the present invention, in step (2), the preservation solution used is formulated as follows: 1% bovine serum albumin, 0.15%-0.25% Tetronic 1307, 2%-3% L-erythrose, and pH 4.5 phosphate buffer added to 100%.
[0019] According to the detection reagent strip described in the first aspect of the present invention, in step (2), the preservation solution used is formulated as follows: 1% bovine serum albumin, 0.2% Tetronic 1307, 2.5% L-erythrose, and pH 4.5 phosphate buffer added to 100%.
[0020] According to the detection reagent strip described in the first aspect of the present invention, in step (2), the preservation solution used is formulated as follows: 1% bovine serum albumin, 0.15% Tetronic 1307, 2% L-erythrose, and pH 4.5 phosphate buffer added to 100%.
[0021] According to the detection reagent strip described in the first aspect of the present invention, in step (2), the preservation solution used is formulated as follows: 1% bovine serum albumin, 0.25% Tetronic 1307, 3% L-erythrose, and pH 4.5 phosphate buffer added to 100%.
[0022] According to the detection reagent strip described in the first aspect of the present invention, in step (2), the preparation method of pH 4.5 phosphate buffer is: take 500 ml of 0.2 mol / L potassium dihydrogen phosphate solution, dilute with water to about 900 ml, add sodium hydroxide test solution to adjust the pH to 4.5, add water to dilute to about 950 ml, then adjust the pH to 4.5 with sodium hydroxide test solution or phosphoric acid test solution, add water to 1000 ml, shake well, and obtain.
[0023] According to the detection reagent strip described in the first aspect of the present invention, in step (2), when the desalted and purified fluorescent microspheres-biotin-anti-Aβ1-42 antibody and the desalted and purified fluorescent microspheres-biotin-sheep anti-chicken IgY are mixed in the preservation solution, the concentration of the anti-Aβ1-42 antibody is 0.6 mg / ml, and the concentration of the goat anti-chicken IgY is 0.12 mg / ml.
[0024] According to the detection reagent strip of the first aspect of the present invention, in step (2), the conjugate pad is 8 mm wide and 300 mm long, and after being cut, it is 8 mm long and 4 mm wide.
[0025] According to the detection reagent strip described in the first aspect of the present invention, in step (2), the width of the conjugate pad is in the range of 5-20 mm and the length is in the range of 100-400 mm, and it is horizontally arranged in the reagent strip / card, and after being cut, it has a length of 5-20 mm and a width of 3-10 mm; for example, the conjugate pad is 8 mm wide and 300 mm long, and after being cut, it has a length of 8 mm and a width of 4 mm.
[0026] According to the detection reagent strip described in the first aspect of the present invention, in step (3), the distance between the detection line and the quality control line is 3-10 mm, for example, 6 mm.
[0027] According to the detection reagent strip described in the first aspect of the present invention, in step (3), the first buffer is a pH 6.8 phosphate buffer containing 1% trehalose, and the second buffer is a pH 6.8 phosphate buffer containing 0.5% trehalose.
[0028] According to the detection reagent strip described in the first aspect of the present invention, in step (3), the nitrocellulose membrane has a width in the range of 10 to 50 mm and a length in the range of 100 to 400 mm, is arranged horizontally in the reagent strip / card, and after being cut, has a length of 10 to 50 mm and a width of 3 to 10 mm; for example, the nitrocellulose membrane has a width of 25 mm and a length of 300 mm, and after being cut, has a size of 25 mm in length and 4 mm in width.
[0029] According to the detection reagent strip of the first aspect of the present invention, in step (4), the assembled detection reagent strip is cut into narrow strips with a width of 4 mm.
[0030] Furthermore, the second aspect of the present invention provides a detection reagent card for detecting Aβ1-42 by fluorescent immunochromatography, comprising: a card shell composed of two pieces, front and back, and a detection reagent strip as described in any one of the first aspects of the present invention assembled in the two pieces of the card shell, a sample addition hole is provided on the front side of the card shell at the sample pad, the liquid to be tested is dripped into the sample addition hole, and the liquid is chromatographed toward the absorbent pad under the action of capillary; in addition, an observation window is provided on the front side of the card shell at the nitrocellulose membrane to allow observation of the detection line and quality control line on the narrow strip.
[0031] Furthermore, the third aspect of the present invention provides a storage solution for pretreating the fluorescent labeled binding pad when preparing the detection reagent strip described in the first aspect of the present invention or the detection reagent card described in the third aspect of the present invention, and the formula thereof is: 1% bovine serum albumin, 0.15%~0.25% Tetronic 1307, 2%~3% L-erythrose, and pH 4.5 phosphate buffer added to 100%.
[0032] The preservation solution according to the third aspect of the present invention has a formula of: 1% bovine serum albumin, 0.2% Tetronic 1307, 2.5% L-erythrose, and pH 4.5 phosphate buffer added to 100%; or, a formula of: 1% bovine serum albumin, 0.15% Tetronic 1307, 2% L-erythrose, and pH 4.5 phosphate buffer added to 100%; or, a formula of: 1% bovine serum albumin, 0.25% Tetronic 1307, 3% L-erythrose, and pH 4.5 phosphate buffer added to 100%.
[0033] The detection reagent strip or detection reagent card of the present invention exhibits excellent effects, such as small fluctuations in the measurement results, and the test can be completed in a shorter time, allowing a wider time window. BRIEF DESCRIPTION OF THE DRAWINGS
[0034] Figure 1 : Schematic diagram of the basic principle of fluorescent immunochromatography.
[0035] Figure 2 :Typical structure of fluorescent immunochromatographic detection reagent strip.
[0036] Figure 3 : Schematic diagram of the assembly of the detection reagent card. DETAILED DESCRIPTION
[0037] The present invention is described in detail below by specific examples. Unless otherwise specified, various materials or reagents used below are easily available from the market.
[0038] Example 1: Detection reagent strip for detecting Aβ1-42 The present invention first provides a detection reagent strip for detecting Aβ1-42, which has a basic structure substantially the same as that of the prior art, as schematically shown in FIG. Figure 2 As shown, the direction of movement of the sample liquid chromatography includes: A base plate 1, and a sample pad 2, a fluorescent labeling binding pad 3, a nitrocellulose membrane 4, and a water-absorbing pad 5 are sequentially arranged on the base plate 1 along the length direction of the base plate 1; One end of the sample pad 2 in the chromatographic moving direction is overlapped above one end of the fluorescent label conjugate pad 3, the other end of the fluorescent label conjugate pad 3 is overlapped above one end of the nitrocellulose membrane 4, and the other end of the nitrocellulose membrane 4 is overlapped below the water absorbent pad 5; A detection line 6 and a quality control line 7 are arranged on the nitrocellulose membrane 4 in sequence from the sample pad 2 to the water absorbent pad 5, the detection line 6 is coated with Aβ1-42 antibody, and the quality control line 7 is coated with chicken IgY antibody; the fluorescent label binding pad 3 is coated with fluorescently labeled anti-Aβ1-42 antibody and fluorescently labeled goat anti-chicken IgY.
[0039] Example 2: Preparation of a test strip and a test card for detecting Aβ1-42 This example refers to the method of Example 1 of CN115932241A and describes how to prepare the detection reagent strip for detecting Aβ1-42 described in Example 1 of the present invention.
[0040] In the present invention, unless otherwise specified, the sample pad and fluorescent label binding pad are made of glass fiber membrane, and the absorbent pad is made of absorbent filter paper.
[0041] 1. Pretreatment of sample pad: The sample pad is soaked in the sample pad buffer for 1 hour. After soaking, it is dried at room temperature for 24 hours.
[0042] The sample pad buffer composition: 1% bovine serum albumin, 0.5% S9, PBS buffer.
[0043] In the present invention, unless otherwise specified, % refers to mass / mass percentage.
[0044] In the present invention, unless otherwise specified, the PBS buffer mentioned refers to a phosphate buffer of pH 6.8, which is prepared as follows: take 500 ml of 0.2 mol / L potassium dihydrogen phosphate solution, dilute with water to about 900 ml, add sodium hydroxide test solution to adjust the pH to 6.8, add water to dilute to about 950 ml, then adjust the pH to 6.8 with sodium hydroxide test solution or phosphoric acid test solution, add water to 1000 ml, shake well, and obtain.
[0045] The sample pad may generally have a width of 10 to 30 mm and a length of 100 to 400 mm, or may be longer to accommodate manufacturing equipment, and is disposed transversely in the reagent strip / card, and after being cut, has a length of 10 to 30 mm and a width of 3 to 10 mm. The sample pad of this embodiment has a width of 25 mm and a length of 300 mm, and after being cut, has a length of 25 mm and a width of 4 mm.
[0046] 2. Pretreatment of fluorescent labeling conjugate pad: The desalted and purified anti-Aβ1-42 antibody was added to the biotin solution to obtain biotin-anti-Aβ1-42 antibody; R-phycoerythrin-labeled streptavidin (PE-SA) was added to the desalted and purified biotin-anti-Aβ1-42 antibody, and stirred at room temperature for 1 hour to obtain PE-SA-biotin-anti-Aβ1-42 antibody; in addition, Take the desalted and purified goat anti-chicken IgY and add it to the biotin solution to obtain biotin-goat anti-chicken IgY; take R-phycoerythrin-labeled streptavidin and add it to the desalted and purified biotin-goat anti-chicken IgY, stir at room temperature for 1 hour, and obtain PE-SA-biotin-goat anti-chicken IgY; [The above biotin solution is prepared with DMSO as solvent to form a solution containing 10% biotin concentration; the addition ratio is: 0.06 mg biotin, 0.6 mg anti-Aβ1-42 antibody, 0.36 mg R-phycoerythrin-labeled streptavidin, or the addition ratio is: 0.06 mg biotin, 0.6 mg goat anti-chicken IgY, 0.36 mg R-phycoerythrin-labeled streptavidin] Next, bovine serum albumin was added to the PE-SA-biotin-anti-Aβ1-42 antibody and PE-SA-biotin-goat anti-chicken IgY to a concentration of 1% for blocking treatment; Add 1 mL of preservation solution to the desalting column, and use the desalting column to separate and purify the blocked PE-SA-biotin-anti-Aβ1-42 antibody and the blocked PE-SA-biotin-goat anti-chicken IgY; the preservation solution composition: 1% bovine serum albumin, 0.1% Tween 20, pH 4.5 phosphate buffer; [pH 4.5 phosphate buffer, the preparation method is: take 500 ml of 0.2 mol / L potassium dihydrogen phosphate solution, dilute with water to about 900 ml, add sodium hydroxide test solution to adjust the pH to 4.5, add water to dilute to about 950 ml, then adjust the pH to 4.5 with sodium hydroxide test solution or phosphoric acid test solution, add water to 1000 ml, shake well, and obtain] The desalted and purified PE-SA-biotin-anti-Aβ1-42 antibody and the desalted and purified PE-SA-biotin-goat anti-chicken IgY in the preservation solution were mixed, and the mixture was sprayed onto a glass cellulose membrane at an amount of 4 μL / cm, and dried at 30°C for 6 hours to obtain a fluorescent labeled binding pad; wherein, when mixed, the concentration of the anti-Aβ1-42 antibody was 0.6 mg / ml, and the concentration of the goat anti-chicken IgY was 0.12 mg / ml.
[0047] The conjugate pad may generally have a width of 5 to 20 mm and a length of 100 to 400 mm, or may be longer to accommodate manufacturing equipment, and is disposed transversely in the reagent strip / card, and after being cut, has a length of 5 to 20 mm and a width of 3 to 10 mm. The conjugate pad of this embodiment has a width of 8 mm and a length of 300 mm, and after being cut, has a length of 8 mm and a width of 4 mm.
[0048] When the fluorescent labeling conjugate pad and the nitrocellulose membrane are pretreated in the present invention, the BioDot RR120 system is used to spray the corresponding reagents. Of course, other brands of equipment can also be used for spraying in this field.
[0049] 3. Pretreatment of nitrocellulose membrane: Aβ1-42 antibody was diluted to 1 mg / mL with a first buffer, and chicken IgY antibody was diluted to 0.5 mg / mL with a second buffer, and the two were sprayed on the detection line and quality control line of the nitrocellulose membrane at an amount of 2 μL / cm and a speed of 6 cm / s (the distance between the detection line and the quality control line can be 3-10 mm, and the distance in this embodiment is 6 mm), and dried at 30° C. for 6 hours to obtain a nitrocellulose membrane containing a detection line and a quality control line; [the first buffer was a pH 6.8 phosphate buffer containing 1% trehalose, and the second buffer was a pH 6.8 phosphate buffer containing 0.5% trehalose] The nitrocellulose membrane can usually be 10-50 mm wide and 100-400 mm long, or can be longer to adapt to manufacturing equipment, and is horizontally arranged in the reagent strip / card, and after being cut, it has a length of 10-50 mm and a width of 3-10 mm. The nitrocellulose membrane of this embodiment has a width of 25 mm and a length of 300 mm, and after being cut, it has a length of 25 mm and a width of 4 mm.
[0050] 4. Assembly of test reagent cards: The pretreated sample pad, the pretreated fluorescent label binding pad, the pretreated nitrocellulose membrane, and the absorbent pad are assembled on a base plate (PVC material), and then cut into narrow strips with a width of 2 to 8 mm (cut into narrow strips with a width of 4 mm in this embodiment) to obtain a detection reagent strip for detecting Aβ1-42 of the structure described in Example 1, and then the narrow strip (detection reagent strip) is assembled into a card shell to obtain a detection reagent card for detecting Aβ1-42.
[0051] like Figure 3 The schematic diagram of assembling the detection reagent card is described, and the narrow strips cut into a width of 2 to 8 mm are assembled into the interior of the card shell 8; the card shell 8 is assembled from two pieces, the front and the back, and a sample addition hole 9 is provided at the sample pad 2 on the front side, and the liquid to be tested drips into the sample addition hole 9, and the liquid is chromatographed toward the absorbent pad 5 under the action of capillary tube; in addition, an observation window 10 is provided at the nitrocellulose membrane 4 on the front side of the card shell 8 to allow observation of the detection line 6 and the quality control line 7 on the narrow strip.
[0052] After the test reagent card is assembled, it can be placed in an aluminum foil bag, add desiccant if necessary, seal it, and store it in a dry environment at room temperature. It can usually be stored for at least 1.5 years.
[0053] Example 3: Preparation of a test strip and a test card for detecting Aβ1-42 This example mainly refers to the method of Example 2 herein to prepare a detection reagent strip for detecting Aβ1-42, the main difference being that fluorescent microspheres are used instead of R-phycoerythrin-labeled streptavidin when processing the fluorescent label conjugate pad.
[0054] 1. Pretreatment of sample pad: Proceed according to the corresponding steps of Example 2.
[0055] 2. Pretreatment of fluorescent labeling conjugate pad: Preparation of fluorescein isothiocyanate-silica core-shell dual-structure fluorescent microspheres: 60 ml of anhydrous ethanol, 2 ml of ammonia water, 3 ml of tetraethyl orthosilicate, 1 ml of ultrapure water and 1 mg of fluorescein isothiocyanate were mixed evenly, reacted in a constant temperature water bath for 8 hours, and then 3% Na 2 SiO 3The microspheres were sealed, and the size of the fluorescent microspheres was controlled by adjusting the pH value of the solution by adding hydrochloric acid. The active groups (-COOH) were modified on the surface of the fluorescent microspheres. The reaction solution was centrifuged at 1000×g for 15 min, the precipitate was collected, and suspended with 0.01M pH4.8 borate buffer, and the microsphere concentration was adjusted to OD450nm=0.2~0.25. Then, 100μL of 50mg / mL ethyl-N,N-dimethylpropylcarbodiimide (EDC) and 150μL of 5mg / mL nitrogen hydroxysuccinimide (NHS) were added, and the mixture was shaken and mixed. After incubation at room temperature for 25min, the mixture was centrifuged at 1000×g for 15min, and the precipitate was vacuum dried for precise stability. It was then suspended with 0.01M pH4.8 borate buffer, and the microsphere concentration was adjusted to OD450 of 0.45~0.5 to obtain a fluorescent microsphere suspension.
[0056] The desalted and purified anti-Aβ1-42 antibody was added to the biotin solution to obtain biotin-anti-Aβ1-42 antibody; the fluorescent microsphere suspension was added to the desalted and purified biotin-anti-Aβ1-42 antibody, and stirred at room temperature for 1 hour to obtain fluorescent microsphere-biotin-anti-Aβ1-42 antibody; in addition, The desalted and purified goat anti-chicken IgY was added to the biotin solution to obtain biotin-goat anti-chicken IgY; the fluorescent microsphere suspension was added to the desalted and purified biotin-goat anti-chicken IgY, and stirred at room temperature for 1 hour to obtain fluorescent microsphere-biotin-goat anti-chicken IgY; [The above biotin solution is prepared with DMSO as solvent to have a biotin concentration of 10%; the addition ratio is: 0.06 mg biotin, 0.6 mg anti-Aβ1-42 antibody, 0.25 mg fluorescent microspheres, or the addition ratio is: 0.06 mg biotin, 0.6 mg goat anti-chicken IgY, 0.25 mg fluorescent microspheres] Next, bovine serum albumin was added to the fluorescent microspheres-biotin-anti-Aβ1-42 antibody and fluorescent microspheres-biotin-goat anti-chicken IgY to a concentration of 1% for blocking treatment; Add 1 mL of preservation solution to the desalting column, and use the desalting column to separate and purify the blocked fluorescent microsphere-biotin-anti-Aβ1-42 antibody and the blocked fluorescent microsphere-biotin-goat anti-chicken IgY; the preservation solution composition: 1% bovine serum albumin, 0.1% Tween 20, pH 4.5 phosphate buffer; [pH 4.5 phosphate buffer, the preparation method is: take 500 ml of 0.2 mol / L potassium dihydrogen phosphate solution, dilute with water to about 900 ml, add sodium hydroxide test solution to adjust the pH to 4.5, add water to dilute to about 950 ml, then adjust the pH to 4.5 with sodium hydroxide test solution or phosphoric acid test solution, add water to 1000 ml, shake well, and obtain] The desalted and purified fluorescent microspheres-biotin-anti-Aβ1-42 antibody and the desalted and purified fluorescent microspheres-biotin-goat anti-chicken IgY in the preservation solution were mixed, and the mixture was sprayed onto a glass cellulose membrane at an amount of 4 μL / cm, and dried at 30°C for 6 hours to obtain a fluorescent labeled binding pad; wherein, when mixed, the concentration of the anti-Aβ1-42 antibody was 0.6 mg / ml, and the concentration of the goat anti-chicken IgY was 0.12 mg / ml.
[0057] The bonding pad is 8 mm wide and 300 mm long, and after being cut, it is 8 mm long and 4 mm wide.
[0058] 3. Pretreatment of nitrocellulose membrane: Proceed according to the corresponding steps of Example 2.
[0059] 4. Assembly of test reagent cards: Proceed according to the corresponding steps of Example 2.
[0060] Example 4: Detection using Aβ1-42 detection reagent card This example examines the performance of the Aβ1-42 detection reagent card with reference to the methods described in existing literature.
[0061] The test was performed at room temperature (23-24°C) using a fully automatic dry fluorescent immunoassay analyzer (LABSIM AFS4000, Lanbo Biotechnology) according to the instruction manual.
[0062] Sample processing: Venous blood from 8 healthy volunteers (aged 68-76 years old) donated from the clinic was allowed to stand at room temperature for 30 minutes, centrifuged at 5000rpm for 10 minutes, serum was drawn, and 8 serums were taken and mixed in equal volume ratios as serum A to be tested; venous blood from 7 Parkinson's disease (PD) patients (aged 71-79 years old) donated from the clinic was allowed to stand at room temperature for 30 minutes, centrifuged at 5000rpm for 10 minutes, serum was drawn, and 7 serums were taken and mixed in equal volume ratios as serum B to be tested. The serum to be tested was stored at -18°C for future use.
[0063] 1. Repeatability of test results The detection reagent cards obtained in Example 2 and Example 3 were used respectively. 10 minutes after the sample solution was added to the sample well, the Aβ1-42 content of the serum A and the serum B to be tested was determined. Each serum was measured 10 times using 10 cards of each reagent card, and the fluorescence intensity was read. The Aβ1-42 reference substance was used for determination in the same way. The Aβ1-42 content in the serum sample was calculated using the fluorescence intensity and concentration data of the reference substance, and the repeatability of the result was calculated. The results are shown in Table 1.
[0064] Table 1: Results of the test kit for measuring serum Aβ1-42 content (pg / ml)
[0065] It can be seen from the results in the table that for each serum, the results measured using the two Aβ1-42 detection reagent cards are basically the same, but in terms of the coefficient of variation of the results, the Aβ1-42 detection reagent card of Example 2 is obviously better than the Aβ1-42 detection reagent card of Example 3, and the former has smaller fluctuations in the measurement results and better repeatability of the measurement results.
[0066] 2. Time required for stable detection Take 6 detection reagent cards of Example 2, add the sample of serum A to be tested, read the fluorescence intensity once every 1 minute from the 3rd minute after the addition of the sample until 15 minutes, that is, 3min, 4min, 5min, ..., 15min readings, and use the Aβ1-42 reference substance for determination in the same way, and calculate the Aβ1-42 content in the serum sample using the fluorescence intensity and concentration data of the reference substance. For each time point, calculate the mean of the 6 results, thereby obtaining the average measurement result (n=6) at each time point of 3 to 15min when the detection reagent card of Example 2 is used to determine the serum A to be tested.
[0067] Take 6 detection reagent cards of Example 3, add samples of serum A to be tested, operate as above, and measure the average measurement results (n=6) at each time point of 3 to 15min when the detection reagent card of Example 3 is measured for serum A to be tested. Take 6 detection reagent cards of Example 2, add samples of serum B to be tested, operate as above, and measure the average measurement results (n=6) at each time point of 3 to 15min when the detection reagent card of Example 2 is measured for serum B to be tested. Take 6 detection reagent cards of Example 3, add samples of serum B to be tested, operate as above, and measure the average measurement results (n=6) at each time point of 3 to 15min when the detection reagent card of Example 3 is measured for serum B to be tested. The test results of the 4 experiments are shown in Table 2 below.
[0068] Table 2: Results of measuring serum Aβ1-42 content (pg / ml) at different times after sample addition
[0069] From the above results, it can be seen that the time to reach a stable measurement result when the test reagent card obtained in Example 2 is used to measure the serum A to be tested and the serum B to be tested is 10~11min, while the time to reach a stable measurement result when the test reagent card obtained in Example 3 is used to measure the serum A to be tested and the serum B to be tested is only 5~6min, and the detection speed is significantly faster than the test reagent card in Example 2, and the test result is basically stable after this time until the end of 15min. It can be seen that the test reagent card in Example 3 can quickly and efficiently measure the Aβ1-42 content, and the test result remains unchanged for a long time after obtaining a reliable result in a short time, which provides a wider measurement window for flexibly arranging the test work, for example, when using the test reagent card in Example 3, the fluorescence result can be read within a wide time of 5~15min, which reduces the pressure of the staff. In other words, in order to pursue higher work efficiency, for example, it is required to complete a sample from adding a sample to the time period that can read accurate results within 15min, the test reagent card in Example 3 allows the fluorescence value to be read within a wide time of 5~15min, while the test reagent card in Example 2 needs to complete the reading of the fluorescence value within a short time of 10~15min.
[0070] According to the above results, the detection reagent strip and detection reagent card for detecting Aβ1-42 prepared using fluorescent microspheres in Example 3 show better detection efficiency than the detection reagent card made of streptavidin labeled with R-phycoerythrin in the prior art, and can significantly reduce the work pressure of the detection personnel. However, the detection reagent card of Example 3 still has improvements in the repeatability of the detection results. The inventors have unexpectedly found that the problem of poor repeatability of the detection results of the detection reagent card of Example 3 can be overcome by changing the composition of the preservation solution used in preparing the fluorescent labeling conjugate pad, as described in Example 5.
[0071] Example 5: Preparation of a test reagent card for detecting Aβ1-42 and investigation of its performance 1. Preparation of test kit for detecting Aβ1-42 Example 51: A test reagent card for detecting Aβ1-42 was prepared by referring to the method of Example 3 herein, except that the formula of the preservation solution used when treating the fluorescent labeling conjugate pad was changed to: 1% bovine serum albumin, 0.2% Tetronic 1307 (MW18600, Braveds, USA), 2.5% L-erythrose (Kaisenlai Technology), pH 4.5 phosphate buffer added to 100%. Example 52: A test reagent card for detecting Aβ1-42 was prepared by referring to the method of Example 3 herein, except that the formula of the preservation solution used when treating the fluorescent labeling conjugate pad was changed to: 1% bovine serum albumin, 0.15% Tetronic 1307, 2% L-erythrose, pH 4.5 phosphate buffer added to 100%. Example 53: A test reagent card for detecting Aβ1-42 was prepared by referring to the method of Example 3 herein, except that the formula of the preservation solution used when treating the fluorescent labeling conjugate pad was changed to: 1% bovine serum albumin, 0.25% Tetronic 1307, 3% L-erythrose, pH 4.5 phosphate buffer added to 100%. Example 54: A test reagent card for detecting Aβ1-42 was prepared by referring to the method of Example 3 herein, except that the formula of the preservation solution used when treating the fluorescent labeling conjugate pad was changed to: 1% bovine serum albumin, 0.1% Tween 20, 2.5% L-erythrose, pH 4.5 phosphate buffer added to 100%. Example 55: A test reagent card for detecting Aβ1-42 was prepared by referring to the method of Example 3 herein, except that the formula of the preservation solution used when treating the fluorescent labeling conjugate pad was changed to: 1% bovine serum albumin, 0.2% Tetronic 1307, 2.5% D-erythrose, pH 4.5 phosphate buffer added to 100%. Example 56: A test reagent card for detecting Aβ1-42 was prepared by referring to the method of Example 3 herein, except that the formula of the preservation solution used when treating the fluorescent labeling conjugate pad was changed to: 1% bovine serum albumin, 0.2% Tetronic 1307, 2.5% glucose, pH 4.5 phosphate buffer added to 100%. Example 57: A test reagent card for detecting Aβ1-42 was prepared by referring to the method of Example 3 herein, except that the formula of the preservation solution used when treating the fluorescent labeling conjugate pad was changed to: 1% bovine serum albumin, 0.2% Tetronic 1307, 2.5% fructose, pH 4.5 phosphate buffer added to 100%.
[0072] 2. Performance evaluation of the repeatability of test results of the test reagent card Next, referring to the method in "1. Repeatability of test results" of Example 4, the Aβ1-42 content in the test serum A and the test serum B was determined using the test reagent cards of Examples 51 to 57. Each serum was measured 10 times using 10 cards of each reagent card to obtain 10 results of the 10 cards. The mean (AV value), standard deviation (SD), and coefficient of variation ( CV The results of the 7 test kits for measuring the Aβ1-42 content (pg / ml) in the serum A to be tested are shown in Table 3.
[0073] Table 3: Results of the test kit for measuring the Aβ1-42 content (pg / ml) in serum A to be tested
[0074] In addition, the results of measuring 10 Aβ1-42 contents (pg / ml) of the test serum B by the detection reagent card of Example 51 were: 1628.4, 1538.7, 1765.4, 1842.1, 1519.2, 1683.2, 1517.6, 1684.2, 1713.8, and 1692.7, with a mean of 1658.53, a SD of 102.54, and a CV of 6.18%. The mean value (n=10) of the result of the detection reagent card for Example 52 for determining the Aβ1-42 content (pg / ml) of the serum B to be tested was 1627.68, SD was 110.37, and CV was 6.78%; the mean value (n=10) of the result of the detection reagent card for Example 53 for determining the Aβ1-42 content (pg / ml) of the serum B to be tested was 1646.53, SD was 115.84, and CV was 7.04%; the mean value (n=10) of the result of the detection reagent card for Example 54 for determining the Aβ1-42 content (pg / ml) of the serum B to be tested was 1662.14, SD was 212.46, and CV was 12.78%; The mean value (n=10) of the results of the detection reagent card for Example 55 for determining the Aβ1-42 content (pg / ml) of the serum B to be tested was 1637.48, SD was 216.83, and CV was 13.24%; the mean value (n=10) of the results of the detection reagent card for Example 56 for determining the Aβ1-42 content (pg / ml) of the serum B to be tested was 1651.36, SD was 215.78, and CV was 13.07%; the mean value (n=10) of the results of the detection reagent card for Example 57 for determining the Aβ1-42 content (pg / ml) of the serum B to be tested was 1642.28, SD was 207.36, and CV was 12.63%.
[0075] It can be seen from these results that the measurement results of the detection reagent cards obtained by the methods of Examples 51 to 57 are basically consistent with the measurement results of the detection reagent cards obtained by the methods of Examples 2 and 3, but only the measurement results of the detection reagent cards of Examples 51 to 53 prepared by using Tetronic 1307 and L-erythrose at the same time are significantly better than those of other reagent cards in repeatability, and this finding is completely unforeseeable by the prior art.
[0076] 3. Performance evaluation of the test kit's determination efficiency With reference to "2. Time required for stable detection" in Example 4 of the present invention, the performance of the detection efficiency of the detection reagent cards of Examples 51 to 53 was examined.
[0077] After measurement, the average serum Aβ1-42 content (pg / ml) at each time point (n=6) from 3min to 15min when the test reagent card of Example 51 measured the test serum A was as follows: 853.6, 958.3, 1118.4、1153.2、 1131.5, 1158.3, 1124.3, 1141.4, 1162.4, 1125.4, 1138.7, 1164.3, 1137.6; When the test reagent card of Example 51 measured the serum B to be tested from 3min to 15min at each time point (n=6), the average serum Aβ1-42 content (pg / ml) was as follows: 1037.2, 1437.8, 1636.4、1652.4、 1644.7, 1638.6, 1656.2, 1643.8, 1648.5, 1662.8, 1628.2, 1639.6, 1647.1; The above results show that the detection reagent card of Example 51 can achieve stable measurement results in 5-6 minutes when measuring two kinds of serum samples. In addition, the detection reagent cards of Example 52 and Example 53 were also examined. The results showed that the two reagent cards could achieve stable measurement results in 5-6 minutes when measuring two kinds of serum samples.
[0078] The above descriptions are merely embodiments of the present invention and are not intended to limit the patent scope of the present invention. Any equivalent structure or equivalent process transformation made using the contents of the present invention specification, or directly or indirectly applied in other related technical fields, are also included in the patent protection scope of the present invention.
Claims
1. A test strip for detecting Aβ1-42 by fluorescent immunochromatography, which moves along the direction of the sample liquid chromatography, including: A bottom plate, and a sample pad, a fluorescent marker binding pad, a nitrocellulose membrane, and a water absorbent pad sequentially arranged on the bottom plate along the length direction of the bottom plate; One end of the sample pad in the chromatographic moving direction is overlapped above one end of the fluorescent label conjugate pad, the other end of the fluorescent label conjugate pad is overlapped above one end of the nitrocellulose membrane, and the other end of the nitrocellulose membrane is overlapped below the water absorbent pad; A detection line and a quality control line are sequentially arranged on the nitrocellulose membrane from the sample pad to the water absorption pad, wherein the detection line is coated with Aβ1-42 antibody, and the quality control line is coated with chicken IgY antibody; the fluorescent labeling binding pad is coated with fluorescently labeled anti-Aβ1-42 antibody and fluorescently labeled goat anti-chicken IgY; The test reagent strip is prepared by a method comprising the following steps: (1) Pretreatment of the sample pad: soaking the sample pad in a sample pad buffer solution, and drying the sample pad at room temperature after soaking to obtain a pretreated sample pad; (2) Pretreatment of fluorescent labeling conjugate pad: Using Na2SiO3 as a blocking agent, ethyl orthosilicate was reacted with fluorescein isothiocyanate, followed by treatment with p-ethyl-N,N-dimethylpropylcarbodiimide and nitrogen hydroxysuccinimide to prepare a fluorescent microsphere suspension of fluorescein isothiocyanate-silica core-shell dual-structure fluorescent microspheres. The desalted and purified anti-Aβ1-42 antibody was added to the biotin solution to obtain biotin-anti-Aβ1-42 antibody; the fluorescent microsphere suspension was added to the desalted and purified biotin-anti-Aβ1-42 antibody, and stirred at room temperature for 1 hour to obtain fluorescent microsphere-biotin-anti-Aβ1-42 antibody; in addition, The desalted and purified goat anti-chicken IgY was added to the biotin solution to obtain biotin-goat anti-chicken IgY; the fluorescent microsphere suspension was added to the desalted and purified biotin-goat anti-chicken IgY, and stirred at room temperature for 1 hour to obtain fluorescent microsphere-biotin-goat anti-chicken IgY; Next, bovine serum albumin was added to the fluorescent microspheres-biotin-anti-Aβ1-42 antibody and fluorescent microspheres-biotin-goat anti-chicken IgY to a concentration of 1% for blocking treatment; 1 mL of preservation solution was added to the desalting column, and the blocked fluorescent microspheres-biotin-anti-Aβ1-42 antibody and blocked fluorescent microspheres-biotin-goat anti-chicken IgY were separated and purified using the desalting column; Mix the desalted and purified fluorescent microspheres-biotin-anti-Aβ1-42 antibody and the desalted and purified fluorescent microspheres-biotin-goat anti-chicken IgY in the preservation solution, spray the mixture onto the glass cellulose membrane at a volume of 4 μL / cm, and dry at 30° C. for 6 hours to obtain a fluorescent labeling conjugate pad; (3) Pretreatment of nitrocellulose membrane: Aβ1-42 antibody was diluted to 1 mg / mL with a first buffer, and chicken IgY antibody was diluted to 0.5 mg / mL with a second buffer, and the two were sprayed on the test line and quality control line of the nitrocellulose membrane at a rate of 6 cm / s at an amount of 2 μL / cm, respectively, and dried at 30° C. for 6 hours to obtain a nitrocellulose membrane containing a test line and a quality control line; (4) Assembly of the detection reagent strip: Assemble the pretreated sample pad, the pretreated fluorescent labeling binding pad, the pretreated nitrocellulose membrane, and the absorbent pad on the bottom plate, and then cut them into narrow strips with a width of 2 to 8 mm, which is the detection reagent strip for detecting Aβ1-42.
2. The detection reagent strip according to claim 1, wherein in step (1): The sample pad was pretreated as follows: the sample pad was soaked in a sample pad buffer for 1 hour, and after the soaking was completed, it was dried at room temperature for 24 hours. The sample pad buffer comprises: 1% bovine serum albumin, 0.5% S9, and PBS buffer; The PBS buffer refers to a phosphate buffer with a pH of 6.8, and its preparation method is as follows: take 500 ml of 0.2 mol / L potassium dihydrogen phosphate solution, dilute with water to about 900 ml, add sodium hydroxide test solution to adjust the pH to 6.8, add water to dilute to about 950 ml, then adjust the pH to 6.8 with sodium hydroxide test solution or phosphoric acid test solution, add water to 1000 ml, shake well, and obtain; and / or, The sample pad has a width of 10 to 30 mm and a length of 100 to 400 mm, is disposed transversely in the reagent strip, and is cut to have a size of 10 to 30 mm in length and 3 to 10 mm in width.
3. The detection reagent strip according to claim 1, wherein in step (2): The operation of preparing fluorescein isothiocyanate-silica core-shell dual-structure fluorescent microspheres is as follows: 60 ml of anhydrous ethanol, 2 ml of ammonia water, 3 ml of tetraethyl orthosilicate, 1 ml of ultrapure water and 1 mg of fluorescein isothiocyanate were mixed evenly, reacted in a constant temperature water bath for 8 hours, and then 3% Na2SiO3 was added to seal the microspheres. The size of the fluorescent microspheres was controlled by adjusting the pH value of the solution by adding hydrochloric acid, and the active groups were modified on the surface of the fluorescent microspheres. The reaction solution was centrifuged at 1000×g for 15 min, the precipitate was collected, and 0.01 M pH 4.8 boric acid was used. The microspheres were suspended in borate buffer, and the concentration of the microspheres was adjusted to OD450nm = 0.2-0.25, and then 100 μL of 50 mg / mL p-ethyl-N,N-dimethylpropylcarbodiimide and 150 μL of 5 mg / mL nitrogen hydroxysuccinimide were added, and the mixture was shaken and mixed. After incubation at room temperature for 25 min, the mixture was centrifuged at 1000 × g for 15 min, and the precipitate was vacuum dried for precise stability, and then suspended in 0.01 M pH 4.8 borate buffer, and the concentration of the microspheres was adjusted to OD450 of 0.45-0.5 to obtain a fluorescent microsphere suspension; The biotin solution was prepared using DMSO as solvent to form a solution containing 10% biotin; The addition ratio is: biotin 0.06 mg, anti-Aβ1-42 antibody 0.6 mg, fluorescent microspheres 0.25 mg, or the addition ratio is: biotin 0.06 mg, goat anti-chicken IgY 0.6 mg, fluorescent microspheres 0.25 mg; The preservation solution used is as follows: 1% bovine serum albumin, 0.15%-0.25% Tetronic 1307, 2%-3% L-erythrose, and pH 4.5 phosphate buffer added to 100%; or, the preservation solution is as follows: 1% bovine serum albumin, 0.2% Tetronic 1307, 2.5% L-erythrose, and pH 4.5 phosphate buffer added to 100%; or, the preservation solution is as follows: 1% bovine serum albumin, 0.15% Tetronic 1307, 2% L-erythrose, and pH 4.5 phosphate buffer added to 100%; or, the preservation solution is as follows: 1% bovine serum albumin, 0.25% Tetronic 1307, 3% L-erythrose, and pH 4.5 phosphate buffer added to 100%; and / or, The preparation method of pH 4.5 phosphate buffer is as follows: take 500ml of 0.2mol / L potassium dihydrogen phosphate solution, dilute it with water to about 900ml, add sodium hydroxide test solution to adjust the pH to 4.5, add water to dilute to about 950ml, then adjust the pH to 4.5 with sodium hydroxide test solution or phosphoric acid test solution, add water to 1000ml, shake well, and you have it.
4. The detection reagent strip according to claim 1, wherein in step (2): When the desalted and purified fluorescent microspheres-biotin-anti-Aβ1-42 antibody and the desalted and purified fluorescent microspheres-biotin-goat anti-chicken IgY in the preservation solution are mixed, the concentration of the anti-Aβ1-42 antibody is 0.6 mg / ml and the concentration of the goat anti-chicken IgY is 0.12 mg / ml; The bonding pad is 8 mm wide and 300 mm long, and after being cut, it is 8 mm long and 4 mm wide; and / or, The width of the conjugate pad is in the range of 5-20 mm and the length is in the range of 100-400 mm. It is arranged horizontally in the reagent strip / card and is cut to form a length of 5-20 mm and a width of 3-10 mm. For example, the conjugate pad is 8 mm wide and 300 mm long, and is cut to form a length of 8 mm and a width of 4 mm.
5. The test reagent strip according to claim 1, wherein in step (3), the distance between the test line and the quality control line is 3-10 mm, for example, 6 mm.
6. The detection reagent strip according to claim 1, wherein in step (3), the first buffer is a pH 6.8 phosphate buffer containing 1% trehalose, and the second buffer is a pH 6.8 phosphate buffer containing 0.5% trehalose.
7. The detection reagent strip according to claim 1, wherein in step (3), the nitrocellulose membrane has a width in the range of 10 to 50 mm and a length in the range of 100 to 400 mm, is disposed transversely in the reagent strip / card, and after being cut has a length of 10 to 50 mm and a width of 3 to 10 mm; for example, the nitrocellulose membrane has a width of 25 mm and a length of 300 mm, and after being cut has a size of 25 mm in length and 4 mm in width.
8. The detection reagent strip according to claim 1, wherein in step (4), the assembled detection reagent strip is cut into narrow strips with a width of 4 mm.
9. A test kit for detecting Aβ1-42 by fluorescent immunochromatography, comprising: It comprises a cartridge consisting of two pieces, front and back, and a detection reagent strip as described in any one of the first aspects of the present invention assembled in the two cartridges. A sample addition hole is arranged on the front side of the cartridge at the sample pad, and a liquid to be tested drips into the sample addition hole. The liquid is chromatographed toward the absorbent pad under the action of capillaries. In addition, an observation window is arranged on the front side of the cartridge at the nitrocellulose membrane to allow observation of the detection line and the quality control line on the narrow strip.
10. A preservative solution for pretreating a fluorescent-labeled conjugate pad when preparing the detection reagent strip according to any one of claims 1 to 8 or the detection reagent card according to claim 9, wherein the formula is: 1% bovine serum albumin, 0.15% to 0.25% Tetronic 1307, 2% to 3% L-erythrose, and a pH 4.5 phosphate buffer solution added to 100%; or, the formula is: 1% bovine serum albumin, 0.2% Tetronic 1307, 2.5% L-erythrose, and a pH 4.5 phosphate buffer solution added to 100%; or, the formula is: 1% bovine serum albumin, 0.15% Tetronic 1307, 2% L-erythrose, and a pH 4.5 phosphate buffer solution added to 100%; or, the formula is: 1% bovine serum albumin, 0.25% Tetronic 1307, 3% L-erythrose, and a pH 4.5 phosphate buffer solution added to 100%.
Citation Information
Patent Citations
Detection reagent card for A beta 1-42 detection and preparation method and application thereof
CN115932241A
Human beta amyloid protein A beta 1-42 detection kit
CN116643055A
Fluorescence immunochromatography releasing agent and application thereof
CN116027024A
Method for elimination of false reactivities in immunoassay for Hepatitis A virus
US20060134647A1
